1853 Phase I study of combination therapy with weekly nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with advanced or recurrent breast cancer. (September 2015) - Ota, D.; Akatsuka, S.; Nishi, T.; Kato, T.; Takeuchi, M.; Munechika, T.; Inagaki, M.; Fukuuchi, A.